Literature DB >> 3805758

Decreased protein kinase C activity in psoriatic versus normal epidermis.

F Horn, F Marks, G J Fisher, C L Marcelo, J J Voorhees.   

Abstract

To study the possible involvement of protein kinase C in psoriasis, we determined the activity of this enzyme in involved and uninvolved epidermis from psoriasis patients as well as in normal epidermis from controls. Protein kinase C activity was measured in the 100,000 g supernatants and in the detergent-solubilized particulate fractions of tissue homogenates after partial purification by DEAE-cellulose chromatography. The total enzyme activities per gram protein for normal, involved, and uninvolved epidermis were 127 +/- 11.9 mU/g, 64.7 +/- 8.6 mU/g, and 88.5 +/- 14.4 mU/g, respectively. The respective values for total enzyme activity per mg DNA were 7.04 +/- 0.48 mU/mg, 4.28 +/- 0.54 mU/mg, and 5.02 +/- 0.66 mU/mg. By both data bases, protein kinase C activity was statistically lower in the psoriatic skin biopsies than in those from control persons, whereas no significant difference was found between involved and uninvolved epidermis from psoriasis patients. We hypothesize that alterations in protein kinase C-mediated processes due to decreased protein kinase C activity may play a significant role in the pathophysiology of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805758     DOI: 10.1111/1523-1747.ep12525380

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice.

Authors:  H Sato; I Sugimoto; T Matsunaga; M Tsuchimoto; T Ohta; H Uno; M Kiyoki
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

2.  Gene expression of protein kinase C subtypes in normal and psoriatic epidermis.

Authors:  A Wevers; U Wirnitzer; H Schaarschmidt; L Hegemann; G Mahrle
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

3.  Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis.

Authors:  J M Lord; J Pongracz
Journal:  Clin Mol Pathol       Date:  1995-04

4.  No evidence for the mutation of ras gene in psoriatic epidermis.

Authors:  H Takahashi; H Iizuka; M Katagiri
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  Immunohistological identification of protein kinase C isozymes in normal and psoriatic epidermis.

Authors:  S Inohara; Y Tatsumi; Y Tanaka; H Tateishi; S Sagami
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

6.  Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase.

Authors:  B K Chen; W C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 7.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01

Review 8.  Biology of the protein kinase C family.

Authors:  C A O'Brian; N E Ward
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

9.  Alterations in protein kinase C system of colonic epithelium during fasting-refeeding. Evidence for protein kinase C independent pathway of enhanced proliferative activity.

Authors:  P A Craven; F R DeRubertis
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.